Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: Merck’s First COVID-19 Vaccine Candidate to Enter Phase 1 Clinical Trial in Q3 (Photo courtesy of Merck)

Merck’s First COVID-19 Vaccine Candidate to Enter Phase 1 Clinical Trial in Q3

Merck (Kenilworth, NJ, USA) has announced that it is accelerating its COVID-19 vaccine development efforts and plans to begin clinical studies of its first vaccine candidate in the third quarter of this year. More...
03 Aug 2020
Image: Researchers Develop Cheaper, Rapid, and Accurate Pooling Strategy for RT-PCR-Based Detection of SARS-CoV-2 (Photo courtesy of Medical College of Georgia at Augusta University)

Researchers Develop Cheaper, Rapid, and Accurate Pooling Strategy for RT-PCR-Based Detection of SARS-CoV-2

A team of researchers have developed a cheaper, rapid, and accurate pooling strategy for the RT-PCR-based detection of SARS-CoV-2 in clinical samples that could have a significant impact on large-scale population screening in the wake of the current COVID-19 pandemic. More...
03 Aug 2020
Image: SARS-CoV-2 RT-PCR diagnostics test (Photo courtesy of Maccura Biotechnology)

Diazyme Partners with Maccura Biotechnology to Launch FDA EUA Approved SARS-CoV-2 RT-PCR Diagnostics Test

Diazyme Laboratories, Inc. (Poway, CA, USA) has entered into a partnership with Maccura Biotechnology (Sichuan, China) for the launch of a FDA EUA approved SARS-COV-2 RT-PCR diagnostics test. More...
03 Aug 2020
Illustration

US FDA Authorizes First Tests from Siemens That Estimate Antibodies from Past COVID-19 Infections

The US Food and Drug Administration has authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in an individual’s blood. More...
03 Aug 2020
Image: New Rapid Test Determines Amount of Neutralizing Antibodies Against SARS-CoV-2 Within Short Period of Time (Photo courtesy of FSVO/Renate Boss)

New Rapid Test Determines Amount of Neutralizing Antibodies Against SARS-CoV-2 Within Short Period of Time

A Swiss-German team of researchers have developed a test that determines the amount of neutralizing antibodies against SARS-CoV-2 within a short period of time. More...
03 Aug 2020
Illustration

Discovery of Endogenous Protein That Prevents Coronavirus from Fusing with Host Cells Could Help Stop COVID-19

An international team of researchers has demonstrated that a protein produced by the human immune system can strongly inhibit coronaviruses, including SARS-CoV-2, thus raising hopes of new therapeutic approaches for the treatment of COVID-19. More...
03 Aug 2020
Illustration

GSK and Sanofi Collaborate with US Government for Development of COVID-19 Recombinant Protein-Based Vaccine

GlaxoSmithKline plc (London, UK) and Sanofi S.A. (Paris, France) will collaborate with the US government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine. More...
03 Aug 2020
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Pediatric Mask
Respire SOFT
Copyright © 2000-2026 Globetech Media. All rights reserved.